Cobalt Pharmaceuticals Email Formats
Pharmaceutical Manufacturing • 
Canada • 21-50 Employees
Cobalt Pharmaceuticals Email Formats
Cobalt Pharmaceuticals uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 45.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 45.6% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 22.3% |
{first name}@company.com | john@company.com | 15.1% |
{first name}{last name}@company.com | johndoe@company.com | 9.8% |
{first name}_{last name}@company.com | john_doe@company.com | 7.2% |
Key Contacts at Cobalt Pharmaceuticals
Pam Lowe
Director, Business Development
Hera Neal
Director Of Sales, Ontario
Company overview
| Headquarters | Canada |
| Websites | |
| NAICS | 3254 |
| SIC | 283 |
| Employees | 21-50 |
About Cobalt Pharmaceuticals
Cobalt Pharmaceuticals is the Canadian member of The Arrow Group, an international company focused primarily on generic pharmaceutical products. On December 2, 2009, the Arrow Group was acquired by Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading U.S. based specialty pharmaceutical company with over $3 billion in annual revenues. The acquisition creates a global pharmaceutical company with operations in many of the world's established and growing markets, and a strong product portfolio and pipeline; creating significant opportunities for long-term growth. On October 31, 2012 Watson Pharmaceuticals announced the Global Generics management team, following the announcement of the completion of the acquisition of the Actavis Group for EUR 4.25 billion. The combination creates the world's third largest generic pharmaceutical company, with anticipated pro forma combined 2012 revenues in excess of $8 billion.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Cobalt Pharmaceuticals has 23 employees across 5 departments.
Departments
Number of employees
Funding Data
Cobalt Pharmaceuticals has never raised funding before.
Cobalt Pharmaceuticals Tech Stack
Discover the technologies and tools that power Cobalt Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
Payment processors
Security
Reverse proxies
Programming languages
Miscellaneous
Operating systems
Font scripts
United States
Germany
Qatar
Spain
United Kingdom
Denmark
Frequently asked questions
4.8
40,000 users
